1. Choi YS, Kim J-Y, Wee WR. Effect of the application of human amniotic membrane rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea. 1998; 17:389–95.
2. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997; 123:303–12.
Article
3. Chun DH, Jeon SL, Lee J-Y, Choi TH. The effect of amniotic membrane transplantation on corneal epithelial cell proliferation. J Korean Ophthalmol Soc. 2002; 43:1746–57.
4. Taylor RJ, Wang MX. Rate of reepithelialization following amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 1998; 39:S1038.
5. Fournier JH, McLachlan DL. Ocular surface reconstruction using amniotic membrane allograft for severe surface disorders in chemical burns: case report and review of the literature. Int Surg. 2005; 90:45–7.
6. Jain S, Rastogi A. Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye. 2004; 18:1251–7.
Article
7. John T. Human amniotic membrane transplantation: past, present, and future. Ophthalmol Clin North Am. 2003; 16:43–65.
8. Barabino S, Rolando M, Bentivoglio G, et al. Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology. 2003; 110:474–80.
Article
9. Shimazaki J, Aiba M, Goto E, et al. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology. 2002; 109:1285–90.
10. Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997; 124:765–74.
Article
11. Meller D, Tseng SC. In vitro conjunctival epithelial differentiation on preserved human amniotic membrane. Invest Ophthalmol Vis Sci. 1998; 39:S428.
12. Tseng SC, Prabhasawat P, Barton K. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998; 116:431–41.
Article
13. Taylor RJ, Wang MX. Rate of reepithelialization following amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 1998; 39:S1038.
14. Kim JS, Kim JC, Na BK, et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000; 70:329–37.
Article
15. Buultmann S, You L, Spandau U, et al. Amniotic membrane down-regulate chemokine expression in human keratocytes. Invest Ophthalmol Vis Sci. 1999; 40:S3044.
16. Tseng SC, Li DQ, Ma X. Downregulation of TGF-b1, b2, b3, and TGF-b receptor II expression in human corneal fibroblasts by amniotic membrane. Invest Ophthalmol Vis Sci. 1998; 39:S428.
17. Rennekampff H-O, Dohrmann P, Fory R, Fandrich F. Evaluation of amniotic membrane as a adhesion prophylaxis in a novel surgical gastroschisis model. J Invest Surg. 1994; 7:187–93.
18. Chin JR, Murphy G, Werb Z. Stromelsin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. J Biol Chem. 1985; 264:1367–76.
19. Dogru M, Tsubota K. Current concepts in ocular surface reconstruction. Semin Ophthalmol. 2005; 20:75–93.
Article
20. SIjiri S, Kobayashi A, Sugiyama K, Tseng SC. Evaluation of visual acuity and color vision in normal human eyes with a sutureless temporary amniotic membrane patch. Am J Ophthalmol. 2007; 144:938–42.